Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
11/28/2013 | US20130316354 Mammalian cytokine; related reagents |
11/28/2013 | US20130316350 Nucleic acid molecules containing recombination sites and methods of using the same |
11/27/2013 | EP2666859A2 Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides |
11/27/2013 | EP2666858A1 Modified iRNA agents |
11/27/2013 | EP2666778A1 Nanoparticle, nanoparticle complex and method of preparing a nanoparticle |
11/27/2013 | EP2666474A1 Peptides and related molecules that modulate nerve growth factor activity |
11/27/2013 | EP2666473A1 Peptides and related molecules that modulate nerve growth factor activity |
11/27/2013 | EP2665832A1 Methods and compositions for modified ethanol inducible promoter systems |
11/27/2013 | EP2665740A1 Polymerase preference index |
11/27/2013 | EP2665739A1 Methods and compositions related to synergistic responses to oncogenic mutations |
11/27/2013 | CN103415302A Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
11/27/2013 | CN103408625A DNA purification method |
11/26/2013 | US8592663 Tobacco nicotine demethylase genomic clone and uses thereof |
11/26/2013 | US8592662 Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom |
11/26/2013 | US8592651 Antimicrobial peptides and uses thereof |
11/26/2013 | US8592649 Functional expression of shuffled yeast nitrate transporter (YNT1) in maize to improve nitrate uptake under low nitrate environment |
11/26/2013 | US8592647 Manipulation of ammonium transporters (AMTs) to improve NUE in higher plants |
11/26/2013 | US8592646 Promoter, promoter control elements, and combinations, and uses thereof |
11/26/2013 | US8592572 Liposome containing shRNA molecule targeting a thymidylate synthase and use thereof |
11/26/2013 | US8592571 RNAi modulation of APOB and uses thereof |
11/26/2013 | US8592570 Compositions and methods for inhibiting expression of an RNA from West Nile virus |
11/26/2013 | US8592569 Small RNA-dependent translational regulatory system in cell or artificial cell model |
11/26/2013 | US8592568 Nucleic acid probes and methods for detecting plasmodium parasites |
11/26/2013 | US8592567 Vaccines and immunotherapeutics using codon-optimized IL-15 and methods for using the same |
11/26/2013 | US8592562 Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects |
11/26/2013 | US8592557 Multimeric TNF receptor fusion proteins and nucleic acids encoding same |
11/26/2013 | US8592542 Porous resin beads and method of producing nucleic acid using the same |
11/26/2013 | US8592390 Immunostimulatory method |
11/26/2013 | US8592389 MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes |
11/26/2013 | US8592388 Targeting MicroRNAs for metabolic disorders |
11/26/2013 | US8592386 Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis |
11/26/2013 | US8592384 Micro-RNA's that regulate muscle cells |
11/26/2013 | US8592202 Biosensors for detecting macromolecules and other analytes |
11/26/2013 | US8592200 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA |
11/26/2013 | US8592197 Functional influenza virus-like particles (VLPs) |
11/26/2013 | US8592196 Modified influenza virus |
11/26/2013 | US8592195 Fungal endoglucanases, their production and use |
11/26/2013 | US8592194 Glucoamylase variants with altered properties |
11/26/2013 | US8592193 High activity mutants of butyrylcholinesterase for cocaine hydrolysis |
11/26/2013 | US8592184 Nucleic acid amplification in the presence of modified randomers |
11/26/2013 | US8592182 High throughput nucleic acid sequencing by spacing |
11/26/2013 | US8592181 Brazzein variant having higher sweetness and method for preparing multi-variant |
11/26/2013 | US8592178 Process for the preparation of testosterone |
11/26/2013 | US8592159 Method for detecting presumed IgA nephropathy and method for screening IgA nephropathy patients |
11/26/2013 | US8592158 Detecting multinucleotide repeats |
11/26/2013 | US8592148 Field-switch sequencing |
11/26/2013 | US8591916 Flavivirus vaccine vector against influenza virus |
11/26/2013 | US8591910 Chemically programmable immunity |
11/26/2013 | US8591909 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
11/26/2013 | CA2541438C The modulation of hyaluronan synthesis and degradation in the treatment of disease |
11/26/2013 | CA2482744C Hiv envelope-cd4 complexes and hybrids |
11/26/2013 | CA2450710C Methods for the simultaneous detection of hcv antigens and hcv antibodies |
11/26/2013 | CA2425072C Wt1 fusion polypeptides and methods for wt1 immunotherapy |
11/26/2013 | CA2417986C Single-labeled oligonucleotide probes |
11/25/2013 | CA2815869A1 Method of determining the genotype relating to hereditary nasal parakeratosis (hnpk) and nucleic acids usable in said method |
11/21/2013 | WO2013173638A1 Compositions and methods for modulating smn gene family expression |
11/21/2013 | WO2013173637A1 Compositions and methods for modulating gene expression |
11/21/2013 | WO2013173635A1 Compositions and methods for modulating gene expression |
11/21/2013 | WO2013173608A1 Compositions and methods for modulating mecp2 expression |
11/21/2013 | WO2013173605A1 Compositions and methods for modulating pten expression |
11/21/2013 | WO2013173599A1 Compositions and methods for modulating hemoglobin gene family expression |
11/21/2013 | WO2013173598A1 Compositions and methods for modulating atp2a2 expression |
11/21/2013 | WO2013173475A2 Primers for analyzing methylated sequences and methods of use thereof |
11/21/2013 | WO2013170735A1 Method for treating and/or preventing lung injury |
11/21/2013 | WO2005042743A8 Humanization of antibodies |
11/21/2013 | US20130312126 Methods and Compositions for RNAi Mediated Inhibition of Gene Expression in Mammals |
11/21/2013 | US20130309752 Polypeptides Having Colanic Acid-Degrading Activity |
11/21/2013 | US20130309173 Methods and compositions for maintenance of a functional wound |
11/21/2013 | US20130306000 Aflaxtoxin Resistant Poultry |
11/20/2013 | EP2664675A1 Primer group for detecting cpg island methylation of p16 gene using methylation-specific fluorescence technique |
11/20/2013 | EP2664672A1 Modified iRNA agents |
11/20/2013 | EP2663672A1 Prognostic signature for oral squamous cell carcinoma |
11/20/2013 | EP2663642A2 Treponema pallidum triplet antigen |
11/20/2013 | EP2292792B1 Compositions, methods and kits for determining the presence of Trichomonas Vaginalis in a test sample |
11/20/2013 | EP2075334B1 EG-VEGF nucleic acids and polypeptides and methods of use |
11/20/2013 | EP1841794B1 Adam-9 modulators |
11/20/2013 | CN1832956B Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same |
11/20/2013 | CN103403543A Colon cancer gene expression signatures and methods of use |
11/20/2013 | CN103403161A Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms |
11/20/2013 | CN103403016A Spatially modified gene expression in plants |
11/20/2013 | CN103403015A Method for immobilising nucleic ligands |
11/20/2013 | CN103397019A Use of interfering RNA in production of transgenic animals |
11/20/2013 | CN101999001B Disease markers and uses thereof |
11/20/2013 | CN101528921B Translocation and mutant ros kinase in human non-small cell lung carcinoma |
11/20/2013 | CN101429262B Porous resin particle having hydroxy group or primary amino group and production method thereof |
11/19/2013 | US8586830 Ioslated TT1 polynucleotide, encoded proteins and vectors for increasing tolerance of plants and microbes to abiotic stresses and the use thereof |
11/19/2013 | US8586728 Oligonucleotides containing high concentrations of guanine monomers |
11/19/2013 | US8586727 Synthetic mimics of miR-34 |
11/19/2013 | US8586726 Tissue-specific MicroRNAs and compositions and uses thereof |
11/19/2013 | US8586725 MicroRNAome |
11/19/2013 | US8586724 Oligonucleotides for amplifying Chlamydophila pneumoniae nucleic acid |
11/19/2013 | US8586723 Genomic morse code |
11/19/2013 | US8586722 Methods of using tubers having genetically modified potato plant cells |
11/19/2013 | US8586721 Antibodies specific for DKK-1 and their uses |
11/19/2013 | US8586720 Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) |
11/19/2013 | US8586559 Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences |
11/19/2013 | US8586557 Therapy of p53 mutant colon adenocarcinoma, breast cancer and lung cancer |
11/19/2013 | US8586555 Immunomodulatory compositions, formulations, and methods for use thereof |
11/19/2013 | US8586531 Erythropoietin immunoglobulin fusion proteins |
11/19/2013 | US8586350 Mechanism of separating and purifying DNA and the like |